Status:

COMPLETED

Darbe Administration in Newborns Undergoing Cooling for Encephalopathy

Lead Sponsor:

University of Utah

Collaborating Sponsors:

Thrasher Research Fund

Conditions:

Hypoxic Ischemic Encephalopathy

Eligibility:

All Genders

Up to 24 years

Phase:

PHASE1

PHASE2

Brief Summary

Selective head cooling or whole body hypothermia has become the standard of care for neonatal hypoxia-ischemia encephalopathy (HIE). Despite early intervention death or major neurodevelopmental disabi...

Eligibility Criteria

Inclusion

  • Infants will be eligible for the DANCE trial if they have a gestational age \> 36 weeks by best obstetric estimate, are \< 12 hours old and have evidence of moderate-severe acute perinatal HIE. Eligibility will also include criteria presently used in the NICU to initiate hypothermia:
  • \< 6 hours after birth
  • History of an acute perinatal event (abruption, cord prolapsed, severe fetal heart rate abnormality)
  • Severe fetal or early (\< 1 hour age) neonatal acidosis: arterial pH ≤ 7.0 or a base deficit ≥ 16m mEq/ L
  • If a blood gas is not available or a blood gas at \<1 hour of age has a pH between 7.01 and 7.15, or a base deficit is between 10 and 15.9 mEq/L, additional criteria will be required:
  • acute perinatal event AND
  • either a 10-min Apgar score ≤ 5 or assisted ventilation initiated at birth and continued for at least 10 minutes.

Exclusion

  • Major congenital and/or chromosomal abnormalities
  • Prenatal diagnosis of brain abnormality or hydrocephalus
  • Severe growth restriction (\< 1800g)
  • Central venous hematocrit \> 65%, platelet count \> 600,000/dL, and/or neutropenia (ANC \< 500 µL)
  • Maternal history of major vascular thrombosis or multiple fetal losses (\> 3 spontaneous abortions)
  • ECMO
  • Infant judged critically ill and unlikely to benefit from neonatal intensive care by the attending neonatologist

Key Trial Info

Start Date :

September 1 2012

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2014

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT01471015

Start Date

September 1 2012

End Date

January 1 2014

Last Update

July 23 2024

Active Locations (7)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (7 locations)

1

University of New Mexico

Albuquerque, New Mexico, United States, 87131-0001

2

Vanderbilt University School of Medicine

Nashville, Tennessee, United States, 37232-9544

3

McKay Dee Hospital- Intermountain Healthcare

Ogden, Utah, United States, 84403

4

University of Utah

Salt Lake City, Utah, United States, 84108

Darbe Administration in Newborns Undergoing Cooling for Encephalopathy | DecenTrialz